Delivery Order SPE2DB20D1109-SPE2DB25FP81D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,958.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was awarded without set-aside designations through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,283.98 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens. This competitive award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $28,271.47 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,085.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on September 26, 2025, with completion targeted for September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 7, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order represents a non-set-aside award issued to support federal pharmaceutical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $4,504.50. This is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,210.83 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on September 5, 2025, with completion scheduled for September 8, 2025. This competitive award, issued without set-aside designation, represents a firm fixed price transaction for pharmaceutical delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $7,436.37 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 4, 2025, with completion scheduled for August 5, 2025. This contract employs firm fixed pricing and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP81DDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,940.80 for Trulicity 0.75 mg/0.5 ml pens on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal medical procurement operations. This delivery order falls under AmerisourceBergen's larger $999,999,999 IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, delivering an extensive portfolio that includes specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/23/25 |